Introduction
There are conflicting data in the literature regarding the relationship between obesity and thyroid hormones or thyroid volume. Most studies have demonstrated clinically and biologically insignificant high thyroid-stimulating hormone (TSH), low tri-iodothyronine (T3), low thyroxin (T4), and increased thyroid volume in the obese population [1] [2] [3] . There are few reports about the relationship between weight loss and thyroid volume and function [4] [5] [6] [7] . In a recent study, we reported higher goiter prevalence and increased thyroid volume in obese women and a reduction in thyroid volume after 1 10% weight loss in obese women [6] .
It is commonly accepted that in addition to genetic predisposition, inadequate thyroid hormone synthesis due to iodine deficiency results in cyclic TSH stimulation,
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Cytokines secreted by adipocytes such as leptin and adiponectin have been shown to be related to thyroid function in some studies [9] [10] [11] [12] . Leptin has been reported to be critical for normal function of the thyroid axis in humans [9] [10] [11] . Similarly, a study showed that circulating adiponectin modulates insulin action and the hypothalamo-thyroidal axis [12] . The relationships between thyroid function-volume and leptin or adiponectin levels are still controversial [9] [10] [11] [12] [13] [14] [15] . Furthermore, to our knowledge, the relationship between reduced thyroid volume and adipocytokine levels during weight loss has not yet been studied. Hence, in this study, we first aimed to evaluate the relationships of baseline thyroid volume and thyroid hormone levels with iodine status, and plasma leptin and serum adiponectin levels. Second, we aimed to investigate whether reduction of thyroid volume during weight loss is related to adipocytokines and urinary iodine excretion in obese women.
Subjects and Methods
We evaluated 98 consecutive obese [body mass index (BMI): 30 kg/m 2 ] premenopausal women, mean age 40.5 8 11.4 years, and 31 non-obese (BMI ranging between 20 and 25 kg/m 2 ) women, mean age 38.6 8 13 years, who were admitted to our endocrinology outpatient clinic. Informed consent was obtained from the subjects. Approval was obtained from the ethics committee of Akdeniz University Medical Faculty. All subjects were measured for weight (kg), height (m) and BMI (kg/m 2 ). Subjects with a history of thyroid disease or positive thyroid auto-antibody or those taking thyroid hormones, anti-thyroidal drugs, or iodine-containing drugs were excluded.
Thyroid function tests, plasma leptin and serum adiponectin levels, and urinary iodine excretion were measured and thyroid ultrasonography was performed at baseline. All obese women had difficulty with diet and exercise and were given medication for obesity: 50 patients were given sibutramine 15 mg/day and the remaining 48 orlistat 360 mg/day. The biochemical parameters mentioned above were reassessed 6 months after the obesity treatment.
Serum TSH, free T3 and free T4 were analyzed with Roche Modular Analytics E170 immunoassay system (Roche Diagnostics, Mannheim, Germany) using electrochemiluminescence immunoassay method (ECLIA). Intra-and inter-assay coefficient of variation for these assays were 1.9 and 2.2% for TSH, 1.3 and 2.1% for free T3, and 1.4 and 2.7% for free T4, respectively. Fasting plasma leptin levels were measured by two-site immunoradiometric assay method (Active Human Leptin IRMA, DSL-23100). Serum adiponectin levels were measured using commercial ELISA kit (Linco Research, St. Charles, Miss, USA). Sensitivity was 0.78 ng/ml, and the intra-and inter-assay variability were 1.8 and 6.2%, respectively. Urinary iodine concentration was determined by a modified Sandell-Kolthoff reaction method, using a urinary iodine assay kit (Bioclone, Hitachi Chemical). The intra-and inter-assay variability were 3.0 and 3.4%, respectively [16] .
Thyroid ultrasonography was performed (high-resolution real-time ultrasonographic scanner, 7.5 MHz probe; Toshiba, Tokyo, Japan) by the same investigator (R.S.) in all the patients with the patient in the supine position with a hyperextended neck. Thyroid volume was expressed in ml and the sum of both lobes was calculated by multiplying the length, width and thickness of each lobe with a corrective factor (0.479) [17] . Existing goiter was defined as a thyroid volume above 18 ml [18] .
Statistical Analyses
Statistical analyses were performed by SPSS statistical software (SPSS v. 10.0, Cary, N.C., USA). Continuous variables were tested for normality according to the Kolmogorov-Smirnov test. The results were presented as means 8 standard deviation if distribution was normal or median (minimum-maximum) if distribution was abnormal. Values of the parameters at baseline and after 6 months were compared by paired t test (if distribution was normal) and Wilcoxon signed ranks test. One-way ANOVA was used to compare the parameters between the groups. Univariate analysis of variance was used to detect the factors that affected thyroid volume. Spearman test was used for correlation analysis. p ! 0.05 was considered statistically significant.
Results
The baseline plasma leptin level (p ! 0.001), serum adiponectin level (p = 0.042) and thyroid volumes (p = 0.048) differed significantly between the control and obese patients ( table 1 ) . However, after adjustment for There were no statistically significant changes in TSH, free T3, free T4, urinary iodine and urinary iodine/creatinine levels during the study period (p 1 0.05). After six months of obesity treatment, BMI (p ! 0.001), thyroid volume (p ! 0.001) and leptin level (p = 0.013) were decreased, whereas adiponectin level (p = 0.018) increased significantly compared with baseline values ( fig. 1 ). The reduction in thyroid volume correlated positively (r = 0.56, p = 0.02) with the reduction in BMI in obese patients. The results of the univariate analysis of variance revealed that the changes in BMI (p = 0.022) and leptin level (p = 0.039) were the only factors significantly affecting the changes in thyroid volume.
Discussion
The primary aim of the present study was to determine whether factors such as iodine status, leptin and adiponectin levels affect the increased thyroid volume in obese women. Increased thyroid volume in obese women can be explained by several factors including thyroid autoimmunity, iodine status, genetic predisposition, obesity-related protein or cytokines [2] . Since 1998, a mandatory iodination program has been implemented in Turkey. Although our obese patients were not iodine-deficient, there was a negative relationship between thyroid volume and urinary iodine levels in these patients. Therefore, in contrary to findings of Stichel et al. [19] , iodine status may play an important role in the increased thyroid volume in obese women.
The relationships between thyroid function or volume and plasma leptin or serum adiponectin levels are still controversial [9] [10] [11] [12] [13] [14] [15] . Circulating leptin and adiponectin have been reported to be critical for normal function of the thyroid axis [8] [9] [10] [11] [12] . For example, leptin stimulates biosynthesis of thyrotropin-releasing hormone in vitro and influences the activity of the hypothalamic-pituitary-thyroid axis in vivo. Moreover, the detection of a leptin receptor in the pituitary gland has raised the possibility that circulating leptin might also act directly to modulate TSH release [20, 21] . In contrast to our results, Iacobellis et al. [13] reported that adiponectin and leptin were associated with TSH in obese euthyroid women. The association between TSH and leptin could be an adaptive response to the high thermogenesis due to the increased amount of fat in obese patients [22] . On the other hand, Gomez et al. [9] reported no correlation between leptin levels and pituitary-thyroid axis, but noted a positive correlation between leptin and thyroid volume. The lack of harmony amongst different results may be related to the study designs and patient populations. We found positive correlations between thyroid volume and BMI, TSH and leptin levels in obese women. Although obese women had high leptin and low adiponectin levels compared to non-obese ones, there were no significant differences between the two groups after adjusting for BMI. Therefore, it might be concluded that these differences may rather be due to obesity instead of increased thyroid volume.
The mechanism for change in thyroid volume during weight loss is not clearly understood. Although we found significant relationships between increased thyroid volume and iodine status in obese women, the decrease in thyroid volume during weight loss was not associated sig- nificantly with iodine status, which indicated that while iodine status may play an important role for increased thyroid volume in obese women, it does not affect changes in thyroid volume. The relationship between reduction in thyroid volume and adipocytokine levels during weight loss has not yet been adequately defined. The present study, in agreement with others [23] [24] [25] , found a significant decrease in leptin and increase in adiponectin levels during weight loss. Serum leptin levels also correlated positively with the reduction in thyroid volume. Furthermore, it was found that changes in BMI and leptin levels were the sole factors affecting the changes in thyroid volume in obese women.
Conclusion
The findings of the present study show that iodine status may play an important role for increased thyroid volume in obese women; however, it does not significantly affect the change in thyroid volume. On the other hand, changes in BMI and leptin levels are significantly related to changes in thyroid volume.
